Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MHLW To Establish Research Team On Tamiflu-Resistant Flu Virus

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare decided to establish a emergency research team to inspect national Tamiflu (oseltamivir) resistant flu virus cases; Japan is the biggest consumer nation for Tamiflu. Japan's National Infectious Diseases Institute has seen recent reports from Miyagi and Shiga Prefectures where Tamiflu-resistant flu virus was found among children. In Europe and the U.S., such reports have been increasing recently. To prepare for a potential spread of such a virus, the MHLW team aims to establish treatment policy guidelines for the virus and gather information on group infection routes and Tamiflu administration. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069804

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel